Onglyza May Increase Death Rate
Onglyza Increased Risk of All-Cause Mortality. A review published by the U.S. Food and Drug Administration (FDA) on April 10, 2015 indicates that Astra Zeneca’s key diabetes drugs—Onglyza (saxagliptin)—may be tied to "a significantly increased risk of all-cause mortality." Onglyza is a key AstraZeneca diabetes product that, in … [Read more...] about Onglyza May Increase Death Rate
Popular Acid Reflux Medication Nexium Linked to Kidney Issues
Recent revelations about Nexium have uncovered kidney side effects in one of the most frequently prescribed treatments for excess stomach acid. Nexium is the brand name for esomeprazole, manufactured by Astra Zeneca. Nexium conditions such as gastroesophageal reflux or Zollinger-Ellison syndrome. It may also be used to prevent … [Read more...] about Popular Acid Reflux Medication Nexium Linked to Kidney Issues
